Skip to content

Protocols

Thanks to our patented technologies, Light Modulation® LLLT and Optimal Power Energy® IPL, the Espansione Ecosystem is the ideal solution for addressing a broad spectrum of anterior and posterior segment conditions, along with dermatologic and trichologic concerns.

In addition to the certified application of LM® LLLT and OPE® IPL for ocular surface pathologies, leading experts in ophthalmology and dermatology globally utilize our technologies to address posterior segment conditions, dermatologic and trichologic issues.

Below, you’ll find an overview of peer-reviewed protocols recommended by our experts.

Legend

Single usage
Joint usage
Pathology Technology Recommended Protocol
> Click on Pathologies to Learn More > No. Treatments > Frequency (Days Apart)
Pathology> MGD/DED Technology OPE® IPL + LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 1 to 3 > Frequency (Days Apart) 5 to 10
Technology OPE® IPL LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 2 to 4 > Frequency (Days Apart) 2 to 10
Pathology> Blepharitis Technology OPE® IPL + LM® LLLT
Blue > Red
Yellow
Recommended Protocol > No. Treatments 2 to 3 > Frequency (Days Apart) 5 to 10
Technology OPE® IPL LM® LLLT
Blue > Red
Yellow
Recommended Protocol > No. Treatments 4 to 5 > Frequency (Days Apart) 5 to 10
Pathology> Chalazion Technology OPE® IPL LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 2 to 4 > Frequency (Days Apart) 4 to 7
Pathology> Demodex Technology OPE® IPL LM® LLLT
Blue > Red
Yellow
Recommended Protocol > No. Treatments 4 to 5 > Frequency (Days Apart) 5 to 10
Pathology> Post-blepharoplasty Technology OPE® IPL LM® LLLT
Red > Yellow
Blue
Recommended Protocol > No. Treatments 2 > Frequency (Days Apart) 1x Immediately Post-Surgery
1x 4 to 7 Post-Surgery
Pathology> Rosacea Technology OPE® IPL + LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 3 to 5 > Frequency (Days Apart) 5 to 10
Technology OPE® IPL LM® LLLT
Blue > Red
Yellow
Recommended Protocol > No. Treatments 4 to 5 > Frequency (Days Apart) 5 to 10
Pathology> Stye Technology OPE® IPL LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 2 to 4 > Frequency (Days Apart) 4 to 7
Pathology> Sjögren’s Syndrome Technology OPE® IPL + LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 4 to 5 > Frequency (Days Apart) 5 to 10
Pathology> Pre-/Post-Surgery
Cataract/Refractive
Technology OPE® IPL LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Treatments 1 to 2 > Frequency (Days Apart) 5 to 10

Age-related macular degeneration (AMD) is commonly classified based on its clinical presentation into early, intermediate, and late stages.

The Age-Related Eye Disease Study (AREDS) provided a detailed classification system that is widely used in research and clinical practice.

— OVERVIEW OF THE CLASSIFICATION

AREDS 1
(Low Risk)

An eye with no or few small drusen (AREDS 1) has a very low risk.

→ AREDS 2
(Moderate Risk)

In early AMD (AREDS 2), patients often have several small drusen or a few medium-sized drusen. There are generally no symptoms in the early stage of AMD.

→ AREDS 3
(Medium Risk)

Intermediate AMD (AREDS 3), is characterized by either many medium-sized drusen or one or more large drusen. There may also be changes in the pigmentation of the retina. Some people start to experience mild to moderate vision loss, but they may not notice any symptoms immediately. Difficulty seeing in low light, mild blurriness in central vision, and difficulty recognizing faces until very close to them can be signs.

AREDS 4
(High Risk)

Late/Advanced AMD (AREDS 4), is where the most significant vision loss occurs, and it is divided dry and wet.

Legend

Joint usage
Pathology Technology iCYCLE 1 → INITIAL mCYCLE1 → MAINTENANCE CYCLES EVERY 6-9 MO.S
> Click on Each Pathology to Dive Deeper > No. of Sessions > No. of Sessions
Pathology > dAMD Age-related Macular Degeneration
AREDS 2, AREDS 3
LM® LLLT (PBM)
Yellow+Red
iCYCLE 1 → INITIAL > No. of Sessions 7-8 3 to 4 Days Apart mCYCLE1 → MAINTENANCE CYCLES EVERY 6-9 MO.S > No. of Sessions ≤ 6 3 to 4 Days Apart

Legend

Single usage
Joint usage
Infrared
Pathology Technology Recommended Protocol
> Week 1 > Week 2 > Week 3 > Week 4
Pathology> Lifting Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
2
> Week 3
1
> Week 4
1
Pathology> Periorbital Wrinkles Technology LM® LLLT
Red+Yellow
Blue
> No. Treatments
> Week 1
2
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> Post-Blepharoplasty Technology > No. Treatments
> Week 1
1x Immediately
Post-Surgery
1x 4 to 7 days
Post-Surgery
> Week 2
/
> Week 3
/
> Week 4
/
Pathology> Intensive Lifting Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
1
> Week 3
1
> Week 4
1
Technology LM® LLLT
Infrared
> No. Treatments
> Week 1
/
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> Drainage & Brightness Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
1
> Week 2
1
> Week 3
2
> Week 4
/
Pathology> Deep Toning Technology LM® LLLT
Infrared
> No. Treatments
> Week 1
2
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> Impure Skin & Acne Vulgaris Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
2
> Week 3
1
> Week 4
1
Pathology> Rosacea Technology LM® LLLT
Red+Blue
Yellow
> No. Treatments
> Week 1
1
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> Couperose Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
2
> Week 3
1
> Week 4
1
Pathology> Superficial Wrinkles Technology LM® LLLT
Red+Yellow
Blue
> No. Treatments
> Week 1
2
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> Superficial Teleangiectasia Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> Epidermal Pigmented Lesions Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
1
> Week 2
1
> Week 3
1
> Week 4
1
Pathology> (Acne) Scarring Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
1
> Week 3
1
> Week 4
1
Pathology Technology Recommended Protocol
> 1 Day Prior > Treatment Day > 1 Day Post > & Days Post
> 1 Day Prior
/
> Treatment Day
Filler/Botox
Treatment
> 1 Day Post
/
> 7 Day Post
/
Pathology> Filler & Botox Enhancement Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> 1 Day Prior
/
> Treatment Day
1
> 1 Day Post
1
> 7 Day Post
1
Technology LM® LLLT
Infrared
> No. Treatments
> 1 Day Prior
1
> Treatment Day
/
> 1 Day Post
1
> 7 Day Post
1
Pathology Technology Recommended Protocol
> Week 1 > Week 2 > Week 3 > Week 4
Pathology> Hand rejuventation & anti-spots Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
2
> Week 3
2
> Week 4
2
Pathology> Neck & Decolleté Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
2
> Week 3
2
> Week 4
2
Pathology Technology Recommended Protocol
> Week 1 > Week 2 > Week 3 > Week 4
Pathology> Seasonal Hair Loss Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments
> Week 1
2
> Week 2
2
> Week 3
2
> Week 4
2
Pathology> Chronic Hair Loss Technology LM® LLLT
Red
Blue
Yellow
 
> No. Treatments
> Week 1 > Week 2 > Week 3 > Week 4 > Week 5 > Week 6 > Week 7 > Week 8 > Week 9
> Week 1
2
> Week 2
2
> Week 3
2
> Week 4
1
> Week 5
1
> Week 6
1
> Week 7
1
> Week 8
1
> Week 9
1
Pathology> Hair Thickening Technology LM® LLLT
Red
Blue
Yellow
> No. Treatments STEP 1:
12 Treatments, one every 4 days
For total days: 48 2
STEP 2:
12 Treatments, one every 7 days
For total days: 84
Get Started Now
Get in touch to find out how you can benefit from the Espansione Ecosystem of Technologies and Solutions.

In compliance with current regulations, let us know which audience you belong to:

You must fill in the form to download the file.

I want to be updated about Espansione products and services

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
I have read the privacy policy and the terms and conditions of the site
This field is required.
I want to be updated about Espansione products and services. You can unsubscribe at any time, by using the “unsubscribe” feature at the bottom of any communication you receive.

Thank you for contacting us.